Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water.: I.: Formation studies

被引:18
作者
Casella, R
Williams, DA
Jambhekar, SS
机构
[1] Zeneca Inc, Zeneca Pharmaceut, Wilmington, DE 19850 USA
[2] Massachusetts Coll Pharm & Allied Hlth Sci, Dept Pharmaceut Sci, Boston, MA 02115 USA
关键词
beta-cyclodextrin; indomethacin; complex formation; ultraviolet; infrared; nuclear magnetic resonance; X-ray diffraction; differential scanning calorimetry; thermogravimetric analysis;
D O I
10.1016/S0378-5173(97)00330-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Five complexes were prepared with beta-cyclodextrin and the insoluble, non-steroidal, anti-inflammatory drug indomethacin. The complexes were found to contain drug, water and ammonia in several unique combinations. It was theorized the complexes were tri-molecular in nature and their formation was controlled by a hydrophobic/hydrophilic balance created within the beta-cyclodextrin ring cavity prior to complex formation. Each complex was characterized by ultraviolet, infrared, nuclear magnetic resonance, powder X-ray diffraction, differential scanning calorimetry, and thermogravimetric techniques. These characterizations revealed distinct differences among the five complexes. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 31 条
[1]   DISPOSITION REQUIREMENTS FOR BINDING IN AQUEOUS-SOLUTION OF POLAR SUBSTRATES IN CYCLOHEXAAMYLOSE CAVITY [J].
BERGERON, RJ ;
CHANNING, MA ;
GIBEILY, GJ ;
PILLOR, DM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1977, 99 (15) :5146-5151
[2]   DEPENDENCE OF CYCLOAMYLOSE-SUBSTRATE BINDING ON CHARGE [J].
BERGERON, RJ ;
CHANNING, MA ;
MCGOVERN, KA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1978, 100 (09) :2878-2883
[3]  
BERGERON RJ, 1984, INCLUSION COMPOUNDS, V3, P417
[4]  
BORKA L, 1974, ACTA PHARM SUEC, V11, P295
[5]   IMPROVEMENT OF DISSOLUTION CHARACTERISTICS OF PIROMIDIC ACID BY DIMETHYL-BETA-CYCLODEXTRIN COMPLEXATION [J].
CELEBI, N ;
NAGAI, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (01) :63-75
[6]  
DUCHENE D, 1987, CYCLODEXTRINS THEIR, P225
[7]  
FRANK SG, 1975, J PHARM SCI, V64
[8]  
FROMMING KH, 1990, MINUTES OF THE FIFTH INTERNATIONAL SYMPOSIUM ON CYCLODEXTRINS, P392
[9]  
HAMADA Y, 1975, CHEM PHARM BULL, V23, P1205
[10]  
IMAIZUMI H, 1980, CHEM PHARM BULL, V28, P2565